Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Regulatory News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.00
Bid: 135.00
Ask: 145.00
Change: 12.50 (9.80%)
Spread: 10.00 (7.407%)
Open: 127.50
High: 140.00
Low: 127.50
Prev. Close: 127.50
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

19 Nov 2019 11:05

RNS Number : 9150T
Faron Pharmaceuticals Oy
19 November 2019
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMLLFILLELALIA
Date   Source Headline
23rd Oct 201811:00 amRNSPrice Monitoring Extension
23rd Oct 20189:06 amRNSSecond Price Monitoring Extn
23rd Oct 20189:00 amRNSPrice Monitoring Extension
22nd Oct 20183:00 pmRNSINTEREST trial update presented at ESICM
18th Sep 20189:23 amRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSFaron announces CTA filing for Clevegen
13th Sep 20187:00 amRNSInterim Results
12th Sep 20187:00 amRNSNew data published on Clever-1 function
8th Aug 201811:05 amRNSSecond Price Monitoring Extn
8th Aug 201811:00 amRNSPrice Monitoring Extension
8th Aug 20187:00 amRNSNotice of Interim Results
9th Jul 20188:45 amRNSHolding(s) in Company
28th Jun 20187:00 amRNSClevegen successful toxicity studies
22nd Jun 20187:00 amRNSHoldings in Company
21st Jun 20183:58 pmRNSDirector/PDMR Shareholding
21st Jun 20189:00 amRNSPrice Monitoring Extension
21st Jun 20187:40 amRNSDirector/PDMR Shareholding
20th Jun 20182:05 pmRNSSecond Price Monitoring Extn
20th Jun 20182:00 pmRNSPrice Monitoring Extension
20th Jun 20188:43 amRNSHolding(s) in Company
18th Jun 20183:42 pmRNSHoldings in Company
15th Jun 20184:40 pmRNSSecond Price Monitoring Extn
15th Jun 20184:35 pmRNSPrice Monitoring Extension
14th Jun 201811:05 amRNSSecond Price Monitoring Extn
14th Jun 201811:00 amRNSPrice Monitoring Extension
14th Jun 20187:00 amRNSBiomarker analysis of Phase III INTEREST trial
31st May 20182:33 pmRNSResult of AGM
31st May 20187:00 amRNSAGM Statement
16th May 20185:53 pmRNSPDMR Shareholding
15th May 20183:14 pmRNSDirector/PDMR Shareholding
15th May 20182:05 pmRNSSecond Price Monitoring Extn
15th May 20182:00 pmRNSPrice Monitoring Extension
15th May 20181:16 pmRNSHoldings in Company
11th May 20184:51 pmRNSHolding(s) in Company
11th May 20181:37 pmRNSHolding(s) in Company
11th May 20181:34 pmRNSHolding(s) in Company
11th May 20187:00 amRNSUpdate on the Phase III INTEREST trial
10th May 201810:05 amRNSNotice of AGM
9th May 20184:40 pmRNSSecond Price Monitoring Extn
9th May 20184:35 pmRNSPrice Monitoring Extension
9th May 201812:54 pmRNSHoldings in Company
8th May 20189:05 amRNSSecond Price Monitoring Extn
8th May 20189:00 amRNSPrice Monitoring Extension
8th May 20187:00 amRNSTop line data from the Phase III INTEREST trial
8th May 20187:00 amRNSFinal Results for the year ended 31 December 2017
25th Apr 201812:43 pmRNSHoldings in Company
21st Mar 20187:00 amRNSNotice of Full Year Results
6th Mar 201812:54 pmRNSHolding(s) in Company
5th Mar 201810:12 amRNSHolding(s) in Company
2nd Mar 20181:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.